Prostate Cancer
Androgen deprivation therapy improves pneumoperitoneum time during laparoscopic radical prostatectomy in Japanese patients with enlarged prostates - Abstract
February 11, 2014
OncoGenex announces target number of events reached in phase 3 SYNERGY trial of custirsen in metastatic castrate-resistant prostate cancer
February 11, 2014
It ain't what you do, it's the way you do it: Five golden rules for transforming prostate-specific antigen screening - Abstract
February 11, 2014
Is "pelvic radiation disease" always the cause of bowel symptoms following prostate cancer intensity-modulated radiotherapy? - Abstract
February 11, 2014
Activity of cabazitaxel in castration-resistant prostate cancer progressing after docetaxel and next-generation endocrine agents - Abstract
February 10, 2014
The impact of robot-assisted radical prostatectomy on the use and extent of pelvic lymph node dissection in the "post-dissemination" period - Abstract
February 10, 2014
Target ablation-Image-guided therapy in prostate cancer - Abstract
February 10, 2014
Decisional regret after robotic-assisted laparoscopic prostatectomy is higher in African American men - Abstract
February 10, 2014
Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: An analysis of five European institutions - Abstract
February 10, 2014
Bone metastases treated with radiopharmaceuticals - Abstract
February 7, 2014
Challenges and Recommendations for Early Identification of Metastatic Disease in Prostate Cancer - Abstract
February 7, 2014
Luteinizing hormone-releasing hormone antagonists for urinary obstruction in prostate cancer - Abstract
February 7, 2014
Change in prostate volume during extreme hypo-fractionation analysed with MRI - Abstract
February 7, 2014